Gil-Millan, P.; Rives, J.; Viladés, D.; García-Osuna, Á.; Genua, I.; Miñambres, I.; Grau-Agramunt, M.; Gich, I.; Camacho, M.; Benitez, S.;
et al. Association of Epicardial Adipose Tissue with Novel Inflammation and Heart Failure Biomarkers in Type 2 Diabetes Patients: Effect of Metabolic Control. J. Clin. Med. 2025, 14, 4687.
https://doi.org/10.3390/jcm14134687
AMA Style
Gil-Millan P, Rives J, Viladés D, García-Osuna Á, Genua I, Miñambres I, Grau-Agramunt M, Gich I, Camacho M, Benitez S,
et al. Association of Epicardial Adipose Tissue with Novel Inflammation and Heart Failure Biomarkers in Type 2 Diabetes Patients: Effect of Metabolic Control. Journal of Clinical Medicine. 2025; 14(13):4687.
https://doi.org/10.3390/jcm14134687
Chicago/Turabian Style
Gil-Millan, Pedro, José Rives, David Viladés, Álvaro García-Osuna, Idoia Genua, Inka Miñambres, Margarita Grau-Agramunt, Ignasi Gich, Mercedes Camacho, Sonia Benitez,
and et al. 2025. "Association of Epicardial Adipose Tissue with Novel Inflammation and Heart Failure Biomarkers in Type 2 Diabetes Patients: Effect of Metabolic Control" Journal of Clinical Medicine 14, no. 13: 4687.
https://doi.org/10.3390/jcm14134687
APA Style
Gil-Millan, P., Rives, J., Viladés, D., García-Osuna, Á., Genua, I., Miñambres, I., Grau-Agramunt, M., Gich, I., Camacho, M., Benitez, S., Julve, J., Sánchez-Quesada, J. L., & Pérez, A.
(2025). Association of Epicardial Adipose Tissue with Novel Inflammation and Heart Failure Biomarkers in Type 2 Diabetes Patients: Effect of Metabolic Control. Journal of Clinical Medicine, 14(13), 4687.
https://doi.org/10.3390/jcm14134687
